Table 2.
No. of patients | No. of events | Univariate | Multivariate | |||||
---|---|---|---|---|---|---|---|---|
P | HR | 95% CI | P | HR | 95% CI | |||
Age (years) | ||||||||
<60 | 62 | 19 | 1 | |||||
≥60 | 58 | 20 | 0.73 | 1.12 | 0.60-2.09 | |||
Sex | ||||||||
Female | 80 | 13 | 1 | |||||
Male | 40 | 26 | 0.96 | 1.02 | 0.52-1.98 | |||
Tumor location | ||||||||
Right | 86 | 8 | ||||||
Left | 34 | 31 | 0.27 | 1.55 | 0.71-3.37 | |||
Histological grade | ||||||||
Well | 26 | 10 | 1 | |||||
Moderate+poor | 94 | 29 | 0.32 | 0.70 | 0.34-1.43 | |||
CEA level | ||||||||
Normal | 82 | 17 | 1 | 1 | ||||
Elevated | 38 | 22 | <0.01 | 3.85 | 2.04-7.28 | <0.01 | 2.85 | 1.45-5.61 |
CA19-9 level | ||||||||
Normal | 102 | 28 | 1 | |||||
Elevated | 18 | 11 | <0.01 | 3.14 | 1.56-6.33 | |||
Invasive depth | ||||||||
T1+2 | 26 | 2 | 1 | 1 | ||||
T3+4 | 94 | 37 | 0.01 | 5.93 | 1.43-24.61 | 0.03 | 5.04 | 1.18-21.45 |
Maximum tumor diameter (cm) | 120 | 39 | <0.01 | 1.24 | 1.07-1.43 | |||
Node involvement | ||||||||
N0 | 72 | 16 | 1 | |||||
N1+2 | 48 | 23 | <0.01 | 2.64 | 1.39-5.01 | |||
Positive nodes | 120 | <0.01 | 1.17 | 1.11-1.24 | <0.01 | 1.11 | 1.04-1.18 | |
TNM stage | <0.01 | 2.39 | 1.43-4.01 | |||||
I | 21 | 1 | 1 | |||||
IIa | 53 | 16 | 0.06 | 6.91 | 0.92-52.12 | |||
IIIb | 46 | 22 | 0.01 | 12.86 | 1.73-95.52 | |||
Adjuvant therapies | ||||||||
Received | 70 | 27 | 1 | |||||
None | 50 | 12 | 0.10 | 0.57 | 0.29-1.12 | |||
BMI (kg/m2) | 120 | 39 | 0.04 | 0.91 | 0.83-0.99 | |||
Preoperative measures | ||||||||
WBC (×109/L) | 120 | 39 | 0.68 | 1.04 | 0.87-1.23 | |||
HGB (g/L) | 120 | 39 | 0.71 | 1.00 | 0.98-1.02 | |||
NLR | 120 | 39 | <0.01 | 1.44 | 1.24-1.67 | <0.01 | 1.35 | 1.16-1.58 |
PLT (×109/L) | 120 | 39 | 0.61 | 1.00 | 1.00-1.00 | |||
ALB (g/L) | 120 | 39 | <0.01 | 0.88 | 0.81-0.96 | <0.01 | 0.90 | 0.83-0.97 |
Postoperative FBG (mmol/L) | 120 | 39 | 0.01 | 0.56 | 0.34-0.88 |
a, bCompared with stage I.